Perspectives of People Living with HIV-1 on Implementation of Long-Acting Cabotegravir Plus Rilpivirine in US Healthcare Settings: Results from the CUSTOMIZE Hybrid III Implementation-Effectiveness Study. Journal of the International AIDS Society, 25: 1-12.

In by AHF